GBM TME exhibits a distinct immune profile, including a high density of immune cells and elevated expression of immune checkpoint molecules such as programmed cell death protein-1 (PD−1) and its ligand PD−L1 [6,7]. The gene discussed is CD274; the disease is glioblastoma.